Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Top UK Healthcare Stocks to Watch in August 2026 as Innovation, Drug Pipelines and Medical Technology Drive Growth

The UK healthcare sector continues attracting investor interest as pharmaceutical innovation, biotechnology, medical devices and digital healthcare reshape global medicine. Unlike many cyclical industries, healthcare companies benefit from relatively stableDemandsupported by ageing populations, rising healthcare expenditure and continuous medical innovation.

Ankur Sharma | 03 August 2026

Why Are Investors Watching Renalytix After New Real-World KidneyIntelX Evidence and Healthcare Integrations?

Renalytix plcLSE:RENX gained 5.09% on 31 July 2026, according to the market-move data supplied in the image, putting the precision-medicine diagnostics company among the stronger small-cap performers of the session.

Ankur Sharma | 31 July 2026

Aptamer Group Share Price Rises: Are Pharma Contracts, Ebola Diagnostics and Licensing the Next Catalysts for LSE:APTA?

Aptamer Group plcLSE:APTA gained 5.26% on 31 July 2026, according to the market-move data supplied in the image, placing the biotechnology company among the session's stronger small-cap performers.

Ankur Sharma | 31 July 2026

Futura Medical plc Stock Jumps 8.18% Today: Are Eroxon, WSD4000 and US Expansion Driving LSE:FUM Higher?

Futura Medical plc (LSE:FUM) shares advanced8.18% on 31 July 2026, according to the supplied market snapshot, putting the specialist consumer healthcare company among the stronger UK-listed percentage gainers of the session.

Ankur Sharma | 31 July 2026

Could Transplant Diagnostics Become Verici DX's Life-Saving Growth Market?

Verici Dx plc (AIM: VRCI) is a UK-listed molecular diagnostics company developing tests that assess the risk of rejection in kidney-transplant patients. Its mission addresses a genuine clinical problem: transplant rejection remains a serious threat to organ survival, and better tools to predict and …

Divya Sood | 31 July 2026

Can Genome Mapping Survive the Biotech Funding Winter?

Bionano Genomics, Inc. is a US-based, Nasdaq-listed life-sciences company (ticker BNGO) that also appears on London screens under the line 0A4K. It champions optical genome mapping (OGM), a technology for detecting large-scale structural variations in DNA that can be missed by other methods. UK …

Divya Sood | 31 July 2026

The Mental-Health Micro-Cap Offering Moonshot Potential—and Serious Risk

Solvonis Therapeutics plc (AIM: SVNS) is a UK-listed clinical-stage biotechnology company focused on developing treatments for substance-use disorders and related mental-health conditions, areas of enormous unmet medical need and significant societal cost. Conditions such as alcohol-use disorder and other addictions affect millions and have …

Divya Sood | 31 July 2026

One Pipeline Update Could Change Everything for Palatin Technologies

Palatin Technologies, Inc. is a US-based, listed biopharmaceutical company (NYSE American: PTN) that also appears on London screens under the line 0KF3. It specialises in developing therapies based on melanocortin receptor systems, a biological pathway involved in inflammation, immune function and other processes. UK …

Divya Sood | 31 July 2026

One Health Group PLC (LSE:OHGR) Extends Upward Momentum as Strong Healthcare Demand Lifts Investor Confidence

One Health Group PLC is an independent healthcare provider that delivers NHS-funded surgical procedures and outpatient services across the United Kingdom. The company has continued benefiting from strong demand for elective care as healthcare systems work to improve patient access and reduce waiting lists. …

Ankur Sharma | 31 July 2026

Faron Pharmaceuticals Oy (LSE:FARN) Gains Momentum as Positive Clinical Progress Strengthens Investor Optimism

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer and other serious diseases. Investor sentiment has improved as recent clinical announcements highlighted encouraging developments within its lead oncology programme, while broader optimism toward innovative biotechnology companies has also …

Ankur Sharma | 31 July 2026
Support

Hi! How can we help you today?

Loading…